SCHEMBL7239497

SCHEMBL7239497

COC(=O)c1cc([N+](=O)[O-])ccc1Nc1nc(-c2ccc3ccccc3c2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 7/20 0.59
▸ MAPT P10636 7/20 0.55
▸ RAB9A P51151 6/20 0.55
▸ RECQL P46063 1/20 0.55
▸ NPC1 O15118 2/20 0.51
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ CSNK2A2 P19784 1/20 0.48
▸ CSNK2B P67870 1/20 0.48
▸ CSNK2A3 Q8NEV1 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ VCP P55072 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ PTGES O14684 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7235882 0.89 CSNK2A1 (0.70) CSNK2A1MAPTRAB9ARECQLNPC1
SCHEMBL7238490 0.84 CSNK2A1 (0.61) CSNK2A1MAPTRAB9ANPC1KMT2A
SCHEMBL7238266 0.81 KMT2A (0.49) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL7231284 0.77 RAB9A (0.74) CSNK2A1MAPTRAB9ANPC1KMT2A
SCHEMBL7228539 0.77 RAB9A (0.74) CSNK2A1MAPTRAB9ANPC1KMT2A
SCHEMBL19435568 0.77 RAB9A (0.61) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL7233250 0.75 RAB9A (0.63) CSNK2A1MAPTRAB9ANPC1KMT2A
SCHEMBL7235764 0.74 RAB9A (0.77) CSNK2A1MAPTRAB9ANPC1KMT2A
SCHEMBL8365504 0.74 SLC6A3 (0.65) MAPTRAB9ANPC1KMT2AMEN1
SCHEMBL7229223 0.73 RAB9A (0.64) CSNK2A1MAPTRAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production TERT, POT1, REV1 CSNK2A1 156/4885MAPT 3335/4885RAB9A 3964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback